21 September 2021

The main purpose of SUNRISE-CRC is to determine whether treatment with a high dose of sunitinib provides a better chance of survival and slows the progression of (colo)rectal cancer (CRC) more than standard treatment with TAS-102. Sunitinib, at a low daily dose, has been approved as a treatment for kidney cancer, but not yet for colorectal and rectal cancer. The standard treatment for metastatic colorectal or rectal cancer in this line is TAS-102, a form of chemotherapy. This study also examines whether certain proteins or other characteristics can be detected in the patient's blood and tumor that are predictive of the effect of the treatment. The biomaterial and associated clinical data are being collected and stored in the SUNRISE-CRC biobank.

  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


New Automated PBMC isolation method introduced in LMI.

21 September 2021

The Radboud Biobank (RB) and the laboratory of Medical Immunology (LMI) are making plans to replace the density gradient centrifugation method with a new automated PBMC isolation method, the AutoMACS Pro Separator.

read more

Health-RI, geared up to accelerate

21 September 2021

The Dutch cabinet has selected Health-RI's National Growth Fund proposal for a national health data infrastructure. On 5 October, the kick-off will take place during a live meeting in Jaarbeurs Media Plaza in Utrecht.

read more

PRECISE sub-biobank

21 September 2021

The aim of the PRECISE biobank is to develop the first, smart multi-modal liquid biopsy test service for the prediction of immune checkpoint inhibitor response in urothelial cancer (UC) patients – the PRECISE IVD.

read more

Lysine Metabolism sub-biobank

21 September 2021

Hereditary metabolic disorders form a large group of more than 1,400 rare disorders in which an error in the DNA causes abnormalities in the process in which proteins, fats and carbohydrates are converted into smaller building materials and energy.

read more

Hyperintense sub-biobank

21 September 2021

Cerebral small vessel disease (SVD), encompasses a collection of pathologies that affect the smallest blood vessels in the brain.

read more